Use of Tunneled Femoral Catheters To Prevent Catheter-Related Infection

A Randomized, Controlled Trial

  1. Jean-François Timsit, MD;
  2. Fabrice Bruneel, MD;
  3. Christine Cheval, MD;
  4. Marie-France Mamzer, MD;
  5. Maïté Garrouste-Orgeas, MD;
  6. Michel Wolff, MD;
  7. Benoît Misset, MD;
  8. Sylvie Chevret, MD, PhD;
  9. Bernard Regnier, MD; and
  10. Jean Carlet, MD
  1. From Hôpital Saint Joseph, Hôpital Bichat-Claude Bernard, Hôpital Necker, and Hôpital Saint Louis, Paris, France.

    Abstract

    Background: The risk for catheter-related infection seems higher with femoral catheters than with catheters inserted at other sites.

    Objective: To evaluate the effect of catheter tunneling on femoral catheter-related infection in critically ill patients.

    Design: Randomized, controlled trial.

    Setting: Three intensive care units at academic hospitals in Paris, France.

    Patients: 345 adult patients requiring a femoral venous catheter for more than 48 hours.

    Intervention: Tunneled or nontunneled femoral catheters.

    Measurements: Time to occurrence of systemic catheter-related sepsis, catheter-related bloodstream infection, and quantitative catheter tip culture with a cutoff of 103 colony-forming units/mL.

    Results: Of 345 randomly assigned patients, 336 were evaluable. Probable systemic catheter-related sepsis occurred in 15 of 168 patients who received a nontunneled femoral catheter (controls) and in 5 of 168 patients who received a tunneled femoral catheter (estimated absolute risk reduction, 6% [95% CI, 0.9% to 11%]). Time to occurrence of catheter-related bloodstream infection was not significantly modified (relative risk, 0.28 [CI, 0.03 to 1.92]; P = 0.18); 3 events occurred in the control group and 1 event occurred in the tunneled-catheter group. After stratification by treatment center and adjustment for variables that were prognostic (use of broad-spectrum antimicrobial agents at catheter insertion) or imbalanced between both groups (mechanical ventilation at insertion), tunnelized catheterization reduced the proportion of patients who developed systemic catheter-related sepsis (relative risk, 0.25 [CI, 0.09 to 0.72]; P = 0.005) and positive quantitative culture of the catheter tip (relative risk, 0.48 [CI, 0.23 to 0.99]; P = 0.045).

    Conclusion: The incidence of femoral catheter-related infections in critically ill patients can be reduced by using subcutaneous tunneling.

    Article and Author Information

    • Grant Support: In part by the Fondation-Hôpital Saint Joseph, Bellon, Eli Lilly & Co., Marion Merrell Dow, Inc., Pfizer, Inc., SmithKline Beecham Pharmaceuticals, Roche Laboratories, Roussel & Diamant, and Wyeth-Lederle. Plastimed provided 50 tunneled catheters.

    • Requests for Reprints: Jean-François Timsit, Réanimation Polyvalente, Hôpital Saint Joseph, 185 rue Raymond Losserand, 75014 Paris, France.

    • Current Author Addresses: Drs. Timsit, Misset, Garrouste-Orgeas, and Carlet: Réanimation Polyvalente, Hôpital Saint Joseph, 185 rue Raymond Losserand, 75014 Paris, France.

    • Drs. Bruneel, Wolff, and Regnier: Clinique de Réanimation des Maladies Infectieuses, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75018 Paris, France.

    • Dr. Cheval: Surgical Intensive Care Unit, Hôpital Saint Joseph, 185 rue Raymond Losserand, 75014 Paris, France.

    • Dr. Mamzer: Réanimation Néphrologique et Transplantation, Hôpital Necker, 75013 Paris, France.

    • Dr. Chevret: Biostatistic Department, Hôpital Saint Louis, 75010 Paris, France.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement